Bristol-Myers gets EU approval for diabetes drug
Monday, October 5, 2009 - 10:56
in Health & Medicine
NEW YORK (AP) -- Drugmaker Bristol-Myers Squibb Co. says its new diabetes drugs, Onglyza, has been approved for sale in the European Union's 27 countries....